Brokerages expect that Inspire Medical Systems (NASDAQ:INSP) will post earnings per share (EPS) of ($0.30) for the current quarter, according to Zacks Investment Research. Three analysts have made estimates for Inspire Medical Systems’ earnings. The lowest EPS estimate is ($0.31) and the highest is ($0.29). The company is expected to issue its next earnings report on Tuesday, February 5th.

On average, analysts expect that Inspire Medical Systems will report full-year earnings of ($6.01) per share for the current fiscal year. For the next fiscal year, analysts forecast that the firm will report earnings of ($1.36) per share, with EPS estimates ranging from ($1.48) to ($1.28). Zacks Investment Research’s EPS averages are an average based on a survey of analysts that cover Inspire Medical Systems.

Inspire Medical Systems (NASDAQ:INSP) last released its quarterly earnings results on Tuesday, November 6th. The company reported ($0.22) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.13. The company had revenue of $13.10 million during the quarter, compared to analyst estimates of $12.86 million. During the same period last year, the firm earned ($3.42) earnings per share. The business’s revenue was up 79.9% compared to the same quarter last year.

Several brokerages have commented on INSP. Zacks Investment Research lowered Inspire Medical Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, November 13th. Berenberg Bank initiated coverage on Inspire Medical Systems in a report on Wednesday, November 28th. They issued a “sell” rating and a $31.00 price target for the company. Finally, Leerink Swann began coverage on Inspire Medical Systems in a report on Monday, October 29th. They issued an “outperform” rating and a $57.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the stock. Inspire Medical Systems has a consensus rating of “Hold” and an average price target of $39.63.

In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 15,000 shares of the firm’s stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $39.89, for a total transaction of $598,350.00. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Randy Ban sold 10,000 shares of Inspire Medical Systems stock in a transaction dated Tuesday, November 20th. The stock was sold at an average price of $40.37, for a total value of $403,700.00. The disclosure for this sale can be found here.

Hedge funds have recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA acquired a new stake in Inspire Medical Systems during the second quarter valued at approximately $4,457,000. Gilder Gagnon Howe & Co. LLC bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $5,010,000. Jennison Associates LLC bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $3,185,000. Wasatch Advisors Inc. bought a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $1,065,000. Finally, Sei Investments Co. acquired a new position in shares of Inspire Medical Systems in the 2nd quarter valued at $1,093,000.

Inspire Medical Systems stock traded down $2.65 during trading on Friday, hitting $41.07. The company’s stock had a trading volume of 306,386 shares, compared to its average volume of 190,501. Inspire Medical Systems has a 1-year low of $22.50 and a 1-year high of $57.87.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks

Get a free copy of the Zacks research report on Inspire Medical Systems (INSP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.